These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity. Burks AW; Sampson HA J Allergy Clin Immunol; 1988 Feb; 81(2):417-23. PubMed ID: 3123539 [TBL] [Abstract][Full Text] [Related]
11. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. Sampson HA; Gerth van Wijk R; Bindslev-Jensen C; Sicherer S; Teuber SS; Burks AW; Dubois AE; Beyer K; Eigenmann PA; Spergel JM; Werfel T; Chinchilli VM J Allergy Clin Immunol; 2012 Dec; 130(6):1260-74. PubMed ID: 23195525 [No Abstract] [Full Text] [Related]
12. Comparative study of commercial food antigen extracts for the diagnosis of food hypersensitivity. Sampson HA J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):718-26. PubMed ID: 2461401 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of food allergy based on oral food challenge test. Ito K; Urisu A Allergol Int; 2009 Dec; 58(4):467-74. PubMed ID: 19847093 [TBL] [Abstract][Full Text] [Related]
14. Validation of novel recipes for double-blind, placebo-controlled food challenges in children and adults. Vlieg-Boerstra BJ; Herpertz I; Pasker L; van der Heide S; Kukler J; Jansink C; Vaessen W; Beusekamp BJ; Dubois AE Allergy; 2011 Jul; 66(7):948-54. PubMed ID: 21255039 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled food challenge in adults in everyday clinical practice: a reappraisal of their limitations and real indications. Asero R; Fernandez-Rivas M; Knulst AC; Bruijnzeel-Koomen CA Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):379-85. PubMed ID: 19483616 [TBL] [Abstract][Full Text] [Related]
16. The dilemma of open or double-blind food challenges in diagnosing food allergy in children: Design of the ALDORADO trial. de Weger WW; Sprikkelman AB; Herpertz CEM; van der Meulen GN; Vonk JM; Kamps AWA; Koppelman GH Pediatr Allergy Immunol; 2022 Jan; 33(1):e13654. PubMed ID: 34435396 [TBL] [Abstract][Full Text] [Related]
17. Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. Cochrane SA; Salt LJ; Wantling E; Rogers A; Coutts J; Ballmer-Weber BK; Fritsche P; Fernández-Rivas M; Reig I; Knulst A; Le TM; Asero R; Beyer K; Golding M; Crevel R; Clare Mills EN; Mackie AR Allergy; 2012 Jan; 67(1):107-13. PubMed ID: 22092081 [TBL] [Abstract][Full Text] [Related]
19. Statistical model for assessing the proportion of subjects with subjective sensitisations in adverse reactions to foods. Briggs D; Aspinall L; Dickens A; Bindslev-Jensen C Allergy; 2001; 56 Suppl 67():83-5. PubMed ID: 11298017 [TBL] [Abstract][Full Text] [Related]
20. Accurate oral food challenge requires a cumulative dose on a subsequent day. Niggemann B; Lange L; Finger A; Ziegert M; Müller V; Beyer K J Allergy Clin Immunol; 2012 Jul; 130(1):261-3. PubMed ID: 22552112 [No Abstract] [Full Text] [Related] [Next] [New Search]